Drug
MV
MV is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_1
4
80%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (80.0%)
N/A1 (20.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient
NCT02338752
unknownnot_applicable
Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)
NCT03217149
completedphase_1
Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient
NCT02338700
completedphase_1
Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient
NCT02338804
completedphase_1
Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient
NCT02338778
Clinical Trials (5)
Showing 5 of 5 trials
NCT02338752Phase 1
Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient
NCT03217149Not Applicable
Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)
NCT02338700Phase 1
Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient
NCT02338804Phase 1
Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient
NCT02338778Phase 1
Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5